Who we are, what we do...

 
FORESIGHT CONSULTING'S expertise lies in our ability to construct and implement unique customized medical imaging surrogate endpoints in pharmaceutical, biotechnology, and medical device clinical development. Using advanced quantitative medical imaging technologies is often the best or only method in which clinical efficacy of a drug or medical device can be established.

FORESIGHT has formed a unique alliance of renowned experts in medical imaging and related technologies, providing a range of independent services tailored to the strategic needs of healthcare and biotechnology product development and marketing.

Changes in FDA regulations advocating the use of medical imaging in clinical trials, combined with rapid technological innovations, have resulted in healthcare organizations experiencing increased difficulty in finding qualified personnel with both imaging and clinical development expertise. Our tailored approach to strategic planning and problem solving provides the client with access to academic and industry leaders in imaging-enabled clinical development technology, with point of service managed by FORESIGHT.

FORESIGHT consultants have proven track records, filling an "unmet need" in the armamentarium for medical product development. We are not, however, a contract research organization. FORESIGHT works primarily with your clinical development and marketing groups to expand their capabilities using medical imaging to:

>	Establish product efficacy and biodistribution early in the development process, improving the "go/no go" decision process
>	Develop clinical studies based upon or integrating quantitative imaging endpoints as surrogate markers of product efficacy
>	Combine imaging and clinical data into a unique integrated informatics product for marketing, sales, and education (Optimage™)